Saliva collection devices are sterile collection kits used for collecting saliva samples safely and effectively. They help in collecting samples of saliva for DNA analysis, steroid hormone analysis, and disease diagnosis. Saliva collection devices offer non-invasive collection methods and simplify sample handling compared to blood or urine testing.
The global Saliva Collection Devices Market is estimated to be valued at US$ 297.27 Millions in 2023 and is expected to exhibit a CAGR of 12% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends in the saliva collection devices market is the rising adoption of non-invasive collection techniques. Saliva-based testing offers a non-invasive alternative to blood collection and helps in reducing the risks of infection, pain, and stress for patients. The procedure is also suitable for vulnerable populations like pediatric, geriatric patients. As non-invasive procedures gain more acceptance, the demand for saliva collection devices is expected to increase significantly during the forecast period.
Strength: Saliva collection devices are non-invasive and easy to use leading to higher patient acceptance and compliance. They provide more reliable results as compared to blood collection.
Weakness: Saliva based testing kits still require amplification and specialized equipment for analysis and readings. Not all tests can be accurately performed with saliva samples.
Opportunity: Growing emphasis on direct-to-consumer testing and home healthcare is driving the demand for saliva collection devices. Increasing application of salivary diagnostic for various conditions will boost the market growth.
Threats: Stringent regulatory guidelines and complexity in procedures may hamper the approval and adoption of new saliva based tests. Reimbursement issues related to saliva testing pose a threat to market growth.
Global Saliva Collection Devices Market Demand is expected to witness high growth, exhibiting CAGR of 12% over the forecast period, due to increasing preference for non-invasive sample collection methods.
North America is currently the largest market for saliva collection devices owing to rising awareness about non-invasive testing options and favorable reimbursement policies. Asia Pacific is expected to demonstrate the highest growth rate during the forecast period fueled by growing healthcare infrastructure and increasing domestic manufacturing of diagnostic kits and products in countries like China and India.
Key players operating in the Saliva Collection Devices market are Abbott, NEOGEN Corporation., Salimetrics, LLC., Oasis Diagnostics Corporation., DiaMetra, Isohelix, OraSure Technologies., Candela Medical, Quest Diagnostics.
Key players are focusing on new product launches, geographic expansion and collaboration with diagnostic players for portfolio strengthening in this rapidly evolving market. For instance, in 2022, OraSure launched the first self-collection non-rapid HIV test approved by USFDA indicating rising application potential of saliva samples.
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it